Erol R. Akdamar - Feb 2, 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
Group President
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Feb 2, 2023
Transactions value $
-$1,382,962
Form type
4
Date filed
2/6/2023, 05:05 PM
Previous filing
Feb 1, 2023
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Sale -$776K -3K -7.95% $258.63 34.7K Feb 2, 2023 Direct F1
transaction HCA Common Stock Options Exercise $408K +9K +25.92% $45.30* 43.7K Feb 3, 2023 Direct
transaction HCA Common Stock Tax liability -$1.01M -3.93K -8.99% $258.08 39.8K Feb 3, 2023 Direct
holding HCA Common Stock 60K Feb 2, 2023 By LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -9K -100% $0.00* 0 Feb 3, 2023 Common Stock 9K $45.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.62 to $258.718, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The stock appreciation rights vested in four equal annual installments beginning on November 6, 2014.